EFFECTS OF ANGIOPEPTIN ON TRANSPLANT ARTERIOSCLEROSIS IN THE RAT

被引：5

作者：

AKYUREK, ML

WANDERS, A

AURIVILLIUS, M

LARSSON, E

FUNA, K

FELLSTROM, BC

机构：

[1] Department of Pathology, University Hospital, Uppsala

[2] Department of Medicine, University Hospital, Uppsala

[3] Ludwig Institute for Cancer Research, Biomedical Centre, Uppsala, S-751 24

来源：

TRANSPLANT INTERNATIONAL | 1995年 / 8卷 / 02期

关键词：

ARTERIOSCLEROSIS; ANGIOPEPTIN; RAT; AORTA TRANSPLANTATION;

D O I：

10.1007/BF00344419

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

The influence of the somatostatin analogue angiopeptin on transplant arteriosclerosis was investigated using two aortic transplantation rat models. One was characterized by ischemia/reperfusion-induced changes in syngeneic transplants while immunologically induced changes dominated in the other allogeneic model. Angiopeptin, 100 mu g/kg per day, was administered continuously until the sacrifice of the rats after 8 weeks. No. additional immunosuppression was used in either model. An image analysis system was used to quantify the intimal and medial thicknesses of the grafts. In the syngeneic grafts, the intimal thickness was less than 50 % of that of control grafts (P < 0.05), but no difference was seen in the allogeneic model. The expression of selected cells, TGF-beta s, and PDGF and PDGF alpha-receptors was detected immunohistochemically and displayed a similar picture in control and angiopeptin-treated grafts in both models. We conclude that angiopeptin has no clear immunosuppressive properties but may counteract ischemia-induced transplant arteriosclerosis.

引用

页码：103 / 110

页数：8

共 40 条

[1]

Agro A., Padol I., Stanisz A.M., Immunomodulatory activities of the somatostatin analogue BIM 23014c: effects on murine lymphocyte proliferation and natural killer activity, Regul Pept, 32, pp. 129-132, (1991)

[2]

Asotra S., Foegh M., Conte J.V., Cai B.R., Ramwell P.W., Inhibition of <sup>3</sup>H-thymidine incorporation by angiopeptin in the aorta of rabbits after balloon angioplasty, Transplant Proc, 21, pp. 3695-3696, (1989)

[3]

Bhathena S.J., Recant L., Somatostatin receptors on circulating human blood cells, Horm Metab Res, 12, pp. 277-278, (1980)

[4]

Bodgen A.E., Taylor J.E., Moreau J.P., Coy D.H., Treatment of R-3327 prostate tumours with a somatostatin analogue (somatuline) as adjuvant therapy following surgical castration, Cancer Res, 50, pp. 2646-2650, (1990)

[5]

Bonventre J.V., Weinberg J.M., Kidney preservation ex vivo for transplantation, Annu Rev Med, 43, pp. 523-553, (1992)

[6]

Cathapermal S.S., Foegh M.L., Rau C.S., Ramwell P.W., Disposition and tissue distribution of angiopeptin in the rat, Drug Metab Dispos, 19, pp. 735-739, (1991)

[7]

Conte J.V., Foegh M., Calcagno D., Wallace R.B., Ramwell P.W., Peptide inhibition of myointimal proliferation following angioplasty in rabbits, Transplant Proc, 21, pp. 3686-3688, (1989)

[8]

Eriksson A., Rorsman C., Ernlung A., Claesson-Welsh L., Heldin C.H., Ligand induced homo- and heterodimerization of platelet-derived growth factor α- and β-receptors in intact cells, Growth Factors, 6, pp. 1-14, (1992)

[9]

Fellstrom B., Dimeny E., Larsson E., Klareskog L., Tufveson G., Rubin K., Importance of PDGF receptor expression in accelerated atherosclerosis-chronic rejection, Transplant Proc, 4, pp. 3689-3691, (1989)

[10]

Fellstrom B., Dimeny E., Foegh M.L., Larsson E., Wanders A., Tufeson G., Accelerated atherosclerosis in heart transplants in the rat simulating chronic vascular rejection: effects of prostacyclin and angiopeptin, Transplant Proc, 23, pp. 525-528, (1991)

← 1 2 3 4 →